Skip to main content

Day: June 29, 2020

Xunlei Announces $20 million Share Buyback Program

SHENZHEN, China, June 29, 2020 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading innovator of shared cloud computing and blockchain technology in China, today announced that the board of directors of the Company has approved a plan under which the Company may repurchase up to $20 million of its shares over the next 12 months (the “Share Buyback Program”). The board will review the share repurchase program periodically and, if needed, adjust its size and terms.Under the Share Buyback Program, repurchases may be made from time to time on the open market at the prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable rules and regulations. The shares to be repurchased...

Continue reading

55 North Mining Inc. enters into a Binding Letter of Intent to Acquire the high grade Last Hope Gold Project in Manitoba Canada

TORONTO, June 29, 2020 (GLOBE NEWSWIRE) — 55 North Mining Inc. (“55 North” or the “Company”) announces that it has entered into a binding letter of intent (“LOI”) with 2552883 Ontario Inc. (“2552883”), whereby 55 North will enter into a business combination with 2552883 (a three cornered amalgamation) whereby the shareholders of 2552883 will become shareholders of 55 North (the “Planned Transaction”).  2552883 is the owner of an option to acquire 100% of the rights, title and interest in the Last Hope Gold Project (“Last Hope”), a high grade gold project located in the emerging Lynn Lake Gold Camp in northern Manitoba.The board of directors of 55 North has also decided to dividend out to its shareholders of record as at the date of the special shareholder’s meeting on August 10, 2020 all of the 100,000,000 shares of European Cobalt...

Continue reading

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020

CANTON, Mass., June 29, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that second quarter of fiscal year 2020 financial results will be reported after the market closes on Monday, August 10.Management will host a conference call at 5:00 p.m. Eastern Time on August 10 to discuss the results of the quarter and provide a corporate update with a question and answer session. Those who would like to participate may dial 866-795-3142 (409-937-8908 for international callers) and provide access code 4153175. A live webcast of the call will also be provided on the investor relations section of the Company’s...

Continue reading

XOMA Added to the Russell 2000® and Russell 3000® Indexes

EMERYVILLE, Calif., June 29, 2020 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) today announced the Company has been added to the Russell 2000® and Russell 3000® Indexes following the annual reconstitution, which took effect after the U.S. market closed on June 26, 2020.“We expect XOMA’s addition to these Russell indexes will enhance the Company’s visibility in the investment community and broaden our shareholder base,” stated Jim Neal, Chief Executive Officer of XOMA. The Russell 3000® Index is a market capitalization-weighted equity index that tracks the performance of the largest 3,000 U.S. stocks.  The Russell 2000® Index measures the performance of the small-cap segment of the U.S. equity market and is a subset of the Russell 3000® Index.  Inclusion in the Russell 2000® Index results in automatic inclusion in the appropriate...

Continue reading

Morphic Therapeutic Presents Positive Preclinical Data Supporting Development of MORF-057 in Inflammatory Bowel Disease at Digestive Disease Week 2020

Receptor occupancy, potency and selectivity data further build MORF-057 preclinical profile as an oral small molecule treatment candidate for IBDIND filing on track for mid-year and phase 1 clinical trial expected third-quarter 2020WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) — Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced a presentation highlighting Morphic’s product candidate MORF-057 at the 2020 Digestive Disease Week (DDW) virtual event. The new data presented at DDW expand on Morphic’s recent oral presentation at the 15th Congress of the European Crohn’s and Colitis Organisation (ECCO), which support MORF-057’s development as a potent, selective, and orally available small molecule inhibitor...

Continue reading

Immunovant Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2020 and Announces Plans for Phase 3 Registrational Trial of IMVT-1401 in Myasthenia Gravis

Based on compelling proof-of-biology for anti-FcRn agents in Myasthenia Gravis (MG), Immunovant has begun preparations to initiate a Phase 3 registrational trial of IMVT-1401 in MGIMVT-1401’s development program is entirely based on a subcutaneous injection formatCash balance as of June 29, 2020, is approximately $280.4 millionNEW YORK, June 29, 2020 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases, today reported financial results for its fiscal fourth quarter and fiscal year ended March 31, 2020. As of today, June 29, 2020, Immunovant’s cash balance is approximately $280.4 million. “We recently strengthened our balance sheet, facilitating the continued advancement of IMVT-1401 as we progress towards our goal of...

Continue reading

Repligen Announces Agreement to Acquire Engineered Molding Technology

WALTHAM, Mass., June 29, 2020 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Albany, New York based Engineered Molding Technology (“EMT”), an innovator and manufacturer of single-use silicone assemblies and components used in the manufacturing of biologic drugs. EMT’s standard and custom molded and over-molded connectors and silicone tubing products are key components in single-use filtration and chromatography systems.Tony J. Hunt, President and CEO of Repligen, said, “The acquisition of EMT expands our line of single-use ProConnex® flow paths, streamlines our supply chain for ATF, and gives us more flexibility as we scale and expand our single-use and systems portfolios.” He continued, “The...

Continue reading

Plus Products Announces Completion of Non-Dilutive Share Exchange and Update to Share Structure

SAN MATEO, Calif., June 29, 2020 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., today announced the completion of a non-dilutive share exchange transaction (the “Transaction”), under which an existing shareholder of the Company exchanged 75,500 Common Shares for 15,100,000 newly created Class B Common Shares (the “Class B Subordinate Voting Shares”), on the basis of 200 Class B Subordinate Voting Shares for each Common Share.  The aggregate value of the exchanged Common Shares (CAD$0.7405 per share, representing an aggregate value of CAD$55,907.75) was equivalent to the aggregate value of the newly issued Class B Subordinate Voting Shares (CAD$0.0037025 per share, representing an aggregate value of CAD$55,907.75).  In aggregate,...

Continue reading

Compass Determines Key Structural Controls on Gold Mineralization at Sodala

TORONTO, June 29, 2020 (GLOBE NEWSWIRE) — Compass Gold Corp. (TSX-V: CVB) (Compass or the Company) is pleased to provide an update on the recently completed drilling at the Sodala prospect, located on the Company’s Sikasso Property in southern Mali (Figure 1).HighlightsDrilling at Sodala identifies a broad, shallow gold target, associated with a shear zoneAir core drilling (9 AC holes, 467 m) intersected gold mineralization within a 280-m wide fault zone cutting artisanal gold workingsFurther geophysical testing and drilling planned on permit to test a large (1,000 m x 500 m) shallow soil anomalyCompass CEO, Larry Phillips, said, “Additional bedrock drilling on the Sankarani East permit has identified gold mineralization within a newly discovered shear zone centred on the Sodala artisanal workings.  The results of this latest drilling...

Continue reading

WSP & Altus Group announce the launch of GeoVerra, a leading geomatics firm in Western Canada and Ontario

MONTREAL and TORONTO , June 29, 2020 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX: WSP) (“WSP”), one of the world’s leading professional services firms and Altus Group Limited (TSX: AIF) (“Altus Group”), a leading provider of software, data solutions and independent advisory services to the global commercial real estate industry, announced today that the previously announced transaction to combine their respective geomatics business units has closed.  The combined entity launched as GeoVerra Inc., forming a leading Canadian geomatics firm with offices in Western Canada and Ontario.With offices in 29 cities and towns across Western Canada and Ontario, GeoVerra is well equipped to serve its clients by offering a broad variety of geomatics services.  Through the combination, GeoVerra has the expertise and scope to take on large, complex...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.